Literature DB >> 31722562

Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.

Elisa Dal Canto1,2, Antonio Ceriello3, Lars Rydén4, Marc Ferrini5, Tina B Hansen6,7, Oliver Schnell8, Eberhard Standl8, Joline Wj Beulens1,9.   

Abstract

The global prevalence of diabetes is predicted to increase dramatically in the coming decades as the population grows and ages, in parallel with the rising burden of overweight and obesity, in both developed and developing countries. Cardiovascular disease represents the principal cause of death and morbidity among people with diabetes, especially in those with type 2 diabetes mellitus. Adults with diabetes have 2-4 times increased cardiovascular risk compared with adults without diabetes, and the risk rises with worsening glycaemic control. Diabetes has been associated with 75% increase in mortality rate in adults, and cardiovascular disease accounts for a large part of the excess mortality. Diabetes-related macrovascular and microvascular complications, including coronary heart disease, cerebrovascular disease, heart failure, peripheral vascular disease, chronic renal disease, diabetic retinopathy and cardiovascular autonomic neuropathy are responsible for the impaired quality of life, disability and premature death associated with diabetes. Given the substantial clinical impact of diabetes as a cardiovascular risk factor, there has been a growing focus on diabetes-related complications. While some population-based studies suggest that the epidemiology of such complications is changing and that rates of all-cause and cardiovascular mortality among individuals with diabetes are decreasing in high-income countries, the economic and social burden of diabetes is expected to rise due to changing demographics and lifestyle especially in middle- and low-income countries. In this review we outline data from population-based studies on recent and long-term trends in diabetes-related complications.

Entities:  

Keywords:  Diabetes; cardiovascular disease; cardiovascular mortality; macrovascular complications; microvascular complications

Year:  2019        PMID: 31722562     DOI: 10.1177/2047487319878371

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  75 in total

1.  Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.

Authors:  Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

Review 2.  Environmental risk factors of type 2 diabetes-an exposome approach.

Authors:  Joline W J Beulens; Maria G M Pinho; Taymara C Abreu; Nicole R den Braver; Thao M Lam; Anke Huss; Jelle Vlaanderen; Tabea Sonnenschein; Noreen Z Siddiqui; Zhendong Yuan; Jules Kerckhoffs; Alexandra Zhernakova; Milla F Brandao Gois; Roel C H Vermeulen
Journal:  Diabetologia       Date:  2021-11-18       Impact factor: 10.122

Review 3.  THE ABCDE'S OF PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE.

Authors:  Roger S Blumenthal; Abdulhamied Alfaddagh
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

4.  Protective effect of cinnamon on diabetic cardiomyopathy in nicotinamide-streptozotocin induced diabetic rat model.

Authors:  Chekkilla Uday Kumar; Singareddy Sreenivasa Reddy; Palla Suryanarayana; Madhoosudan A Patil; Periketi Madhusudana Chary; Putcha Uday Kumar; Geereddy Bhanuprakash Reddy
Journal:  J Diabetes Metab Disord       Date:  2022-01-21

5.  The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus.

Authors:  Xue Tian; Yu Gao; Min Zhong; Mowei Kong; Lihua Zhao; Zengbin Feng; Qitian Sun; Jianqiu He; Xiaoyan Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-06-21       Impact factor: 2.174

Review 6.  Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability.

Authors:  Ye Huang; Long Yue; Jiahuang Qiu; Ming Gao; Sijin Liu; Jingshang Wang
Journal:  Horm Metab Res       Date:  2022-07-14       Impact factor: 2.788

7.  Depletion of adipocyte sphingosine kinase 1 leads to cell hypertrophy, impaired lipolysis, and nonalcoholic fatty liver disease.

Authors:  Andrea K Anderson; Johana M Lambert; David J Montefusco; Bao Ngan Tran; Patrick Roddy; William L Holland; L Ashley Cowart
Journal:  J Lipid Res       Date:  2020-07-20       Impact factor: 5.922

8.  Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?

Authors:  Peter R T Bowman; Godfrey L Smith; Gwyn W Gould
Journal:  PeerJ       Date:  2021-05-25       Impact factor: 2.984

9.  β-Hydroxybutyrate inhibits histone deacetylase 3 to promote claudin-5 generation and attenuate cardiac microvascular hyperpermeability in diabetes.

Authors:  Bin Li; Yijin Yu; Kun Liu; Yuping Zhang; Qi Geng; Feng Zhang; Yanning Li; Jinsheng Qi
Journal:  Diabetologia       Date:  2020-10-27       Impact factor: 10.122

10.  Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.

Authors:  Stelios Karayiannides; Catarina Djupsjö; Jeanette Kuhl; Claes Hofman-Bang; Anna Norhammar; Martin J Holzmann; Pia Lundman
Journal:  Cardiovasc Diabetol       Date:  2021-06-14       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.